EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multimodal Multiorgan‐on‐a‐Chip Platform for Probing Liver‐Tumor Interactions and Advancing Prodrug Screening

Dan Wang, Yisong Huang, Weijian Zhao, Tian Chen, Siyu Bai, Denghui Guo, Mengying Wang, Yaoyao Zhao, Liang Zhao, Guangsheng Guo, Xiayan Wang iD

Advanced Science · 2026-06 · 13 (34)

DOI: 10.1002/advs.202600040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 07.04.2026. Verfasst von Dan Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Materials Low-Carbon Recycling, Beijing Key Laboratory of Cardiopulmonary-Cerebral Resuscitation Innovation and Translation, …. Hauptthemen laut MEDLINE: Prodrugs, Liver Neoplasms, Lab-On-A-Chip Devices, Liver. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Outstanding Young Scientist Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To advance the development of microphysiological systems with enhanced metabolic fidelity, there is a critical need to recapitulate native three‐dimensional multicellular architecture, enabling non‐invasive, multi‐parameter measurements. Here, we present a multimodal multi‐OoC platform designed to investigate liver‐tumor interactions and streamline prodrug screening. The platform features a sophisticated microfluidic circuit with pneumatically actuated valves for dynamic perfusion and strategically configured microwell arrays that support the formation and maturation of 3D hepatic constructs. By synergistically incorporating real‐time electrochemical sensing with automated solid‐phase microextraction coupled to mass spectrometry (SPME‐LC‐MS) for pharmaceutical kinetic analysis, the platform allows nonintrusive, longitudinal monitoring of prodrug metabolism. We further implemented an impedance‐based immunosensor for real‐time assessment of drug‐induced hepatotoxicity, quantifying secreted albumin across clinically relevant concentrations (1–80 µM). As proof of concept, we evaluated the metabolic activation and subsequent antineoplastic efficacy of two prodrugs, capecitabine and tamoxifen, highlighting the system's ability to elucidate hepatic metabolic activation pathways and resultant antineoplastic efficacy. By unifying 3D tissue models with complementary real‐time analytical modalities, this work provides a versatile and transformative approach for in vitro drug evaluation and mechanistic organ‐organ interaction studies. L. Z. conceived the study. D. W. performed the experiments, analyzed the data, and wrote the manuscript. L. Zhao. wrote and revised the manuscript. X. W., and G. G. helped on revising the manuscript. D. G., M. W., and Y. Z. helped to perform the mass spectrometry testing of the parent drug and its metabolites. T. C. assisted in completing all the work related to the proteomics section. Y. H. and S. B. assisted in the fabrication and characterization of the chip. L. Z. and X. W. supervised the research project. All authors read and approved the final manuscript.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsLiver NeoplasmsLab-On-A-Chip DevicesLiverAntineoplastic AgentsMicrophysiological SystemsHumansAnimals

Stichwörter der Autor:innen

liver metabolismliver‐tumor interactionmultimodal analysismultiorgan‐on‐a‐chipprodrug

Substanzen

ProdrugsAntineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Materials Low-Carbon Recycling, Beijing Key Laboratory of Cardiopulmonary-Cerebral Resuscitation Innovation and Translation, Center of Excellence for Environmental Safety and Biological Effects,…

ORCID-Profile: Xiayan Wang

Förderung

  • National Natural Science Foundation of China
  • Beijing Outstanding Young Scientist Program

Zitieren

APA

Wang, D., Huang, Y., Zhao, W., Chen, T., Bai, S., Guo, D., Wang, M., Zhao, Y., Zhao, L., Guo, G., & Wang, X. (2026). Multimodal Multiorgan‐on‐a‐Chip Platform for Probing Liver‐Tumor Interactions and Advancing Prodrug Screening. Advanced Science, 13(34). https://doi.org/10.1002/advs.202600040

Vancouver

Wang D, Huang Y, Zhao W, Chen T, Bai S, Guo D, et al. Multimodal Multiorgan‐on‐a‐Chip Platform for Probing Liver‐Tumor Interactions and Advancing Prodrug Screening. Advanced Science. 2026;13(34). doi:10.1002/advs.202600040

BibTeX
@article{Wang2026,
  author = {Wang, Dan and Huang, Yisong and Zhao, Weijian and Chen, Tian and Bai, Siyu and Guo, Denghui and Wang, Mengying and Zhao, Yaoyao and Zhao, Liang and Guo, Guangsheng and Wang, Xiayan},
  title = {Multimodal Multiorgan‐on‐a‐Chip Platform for Probing Liver‐Tumor Interactions and Advancing Prodrug Screening},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {34},
  doi = {10.1002/advs.202600040}
}
Kostenlos starten →